NCT03001505

Brief Summary

This is an observational, prospective and retrospective registry of patients with pancreatic cancer treated in Duke University Health System, which will examine patient and treatment effects on cancer outcomes.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
129mo left

Started May 2017

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
May 2017Apr 2037

First Submitted

Initial submission to the registry

December 15, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 23, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

May 4, 2017

Completed
19.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2037

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2037

Last Updated

December 6, 2017

Status Verified

December 1, 2017

Enrollment Period

19.9 years

First QC Date

December 15, 2016

Last Update Submit

December 4, 2017

Conditions

Pancreatic Cancer

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    Survival from Diagnosis to time of death

    10 years

Secondary Outcomes (3)

  • Disease-free survival

    10 years

  • Metastasis

    10 years

  • Local recurrence

    10 years

Study Arms (1)

Patients with pancreatic cancer

Patients diagnosed with pancreatic cancer evaluated at this institution.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with pancreatic cancer who are treated at DUHS

You may qualify if:

  • Pancreatic cancer

You may not qualify if:

  • Younger than 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Duke University Health System

Durham, North Carolina, 27710, United States

Location

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Study Officials

  • Sabino Zani, MD

    DUHS

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2016

First Posted

December 23, 2016

Study Start

May 4, 2017

Primary Completion (Estimated)

April 1, 2037

Study Completion (Estimated)

April 1, 2037

Last Updated

December 6, 2017

Record last verified: 2017-12

Data Sharing

IPD Sharing
Will not share

Locations

US(2)